https://www.selleckchem.com/products/ots964.html
None of our results rose to the level of statistical significance. TXA administration significantly reduced odds of death on logistic regression (OR, 0.35; 95% CI, 0.123-0.995; p = 0.0488). CONCLUSIONS Use of TXA in pediatric patients with combat trauma requiring massive transfusions trended towards a significant improvement in in-hospital mortality (p-value 0.055). This mortality benefit is similar to that seen in adult studies and less well characterized cohort in another pediatric study suggesting TXA administration confers mortality
Like
Comment
Share
